South America Medical Oxygen Concentrators Market

At what CAGR is the South America Medical Oxygen Concentrators Market anticipated to augment?

• The South America medical oxygen concentrators market is valued at US$ 275.18 Mn in 2018 and is expected to grow at a CAGR of 7.2% over the forecast period to reach a US$ YY Mn by 2026.

What is the key driving factor of the South America Medical Oxygen Concentrators Market?

The rising prevalence of asthma and COPD is one of the key factors driving the South America medical oxygen concentrators market

• Increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD) and asthma diseases are driving medical oxygen concentrators market as these patients require purified oxygen
• The prevalence of chronic lung disorders such as COPD and pneumonia is high among the older population as the respiratory muscle strength decreases as age progresses
• COPD is the most common disease in elderly population. It is a progressive illness that takes several years to develop. Most people are at least 40 years old when symptoms of COPD first appear. It’s not impossible to develop COPD as a young adult, but it is rare.
• Adults  tend to have more persistent symptoms of asthma, occupational asthma is the most common type of asthma observed in adults.
• According to Brazil Statistical Institute in 2017, in Brazil, people aged 65 and above are expected to reach 36% by 2050 and major percentage of asthma and COPD patients are of geriatric population
• According to the National Health Survey in 2018, in Brazil, asthma effected more than 6 million adults
• According to the World Bank in 2016, 7.64% of South America population was adult population

Who are the leading players in the South America Medical Oxygen Concentrators Market?

Philips Healthcare, ResMed Inc, Fisher & Paykel Healthcare Corporation Limited, Inogen Inc, Invacare Corporation, Dragerwerk AG & Co KGaA, .Etc.

Philips Healthcare

• Philips healthcare is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. . 
• Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. 
• The Company's Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. 
• The Company's Healthcare Informatics, Solutions and Services comprises healthcare IT, clinical and visualization and quantification informatics solutions for radiology, cardiology, oncology and neurology departments.
• Philips healthcare offers 450+ products or services  over 100+ countries with an annual revenue around 9.6 billion euros.
• Philips Healthcare, generated revenue of $20.24 billion , $19.89 billion and $19.48 billion for the years ended December 31, 2018 , 2017 and 2016 , respectively. This represents annual increases of 1.76% and 2.1% , respectively
• In 2018 , 52% of Philips revenue was generated from US. Philips sales outside of the United States are denominated principally in the West Europe , with some sales being denominated in other countries. 
• Net income of Philips Healthcare amounted to EUR $1.23 billion,  which is a decrease of $864 million compared to 2017, mainly due to the deconsolidation of Signify (formerly Philips Lighting).

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com